Published in FEBS Lett on May 10, 1993
Multivariate proteomic analysis of murine embryonic stem cell self-renewal versus differentiation signaling. Proc Natl Acad Sci U S A (2004) 1.17
Constitutive c-myb expression in K562 cells inhibits induced erythroid differentiation but not tetradecanoyl phorbol acetate-induced megakaryocytic differentiation. Mol Cell Biol (1995) 0.92
Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Eukaryotic Signal Transduction Group. Neuron (1993) 1.57
Poliovirus morphogenesis. I. Identification of 80S dissociable particles and evidence for the artifactual production of procapsids. J Virol (1981) 1.31
Accumulation of m-iodobenzylguanidine by neuroblastoma cells results from independent uptake and storage mechanisms. Cancer Res (1991) 1.08
Minimal disease monitoring by QRT-PCR: guidelines for identification and systematic validation of molecular markers prior to evaluation in prospective clinical trials. J Pathol (2008) 1.03
Expression of a gene for mouse eucaryotic elongation factor Tu during murine erythroleukemic cell differentiation. Mol Cell Biol (1987) 1.03
Fibrocartilaginous mesenchymoma of bone. Pathol Res Pract (1991) 0.99
A combined evaluation of biochemical and morphological changes during human neuroblastoma cell differentiation. Cell Mol Neurobiol (1992) 0.98
Allogeneic adipose tissue-derived mesenchymal stem cells in combination with platelet rich plasma are safe and effective in the therapy of superficial digital flexor tendonitis in the horse. Int J Immunopathol Pharmacol (2013) 0.95
Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule. Histopathology (2008) 0.93
Expression of costimulatory molecules in human neuroblastoma. Evidence that CD40+ neuroblastoma cells undergo apoptosis following interaction with CD40L. Br J Cancer (2003) 0.91
Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity. Cancer Res (1996) 0.90
Multi-image based method to correct vignetting effect in light microscopy images. J Microsc (2012) 0.90
Effects of gamma-interferon on the growth, morphology, and membrane and cytoskeletal proteins expression of Lan-1 cells. Exp Cell Res (1989) 0.89
Induction of monocyte-macrophage differentiation in a new diploid line of human hematopoietic cells (CM-S) by phorbol esters. Cancer Res (1982) 0.88
gamma-Interferon increases metaiodobenzylguanidine incorporation and retention in human neuroblastoma cells. Cancer Res (1992) 0.87
T cells from lymphoepithelial thymoma produce a biochemical variant of IL-2. Lymphokine Res (1985) 0.86
Morphologic and phenotypic changes of human neuroblastoma cells in culture induced by cytosine arabinoside. Exp Cell Res (1989) 0.86
Uncoordinate induction and differential regulation of HLA class-I and class-II expression by gamma-interferon in differentiating human neuroblastoma cells. Int J Cancer (1993) 0.85
Angiogenic and angiostatic microenvironment in tumors--role of gangliosides. Acta Oncol (1997) 0.85
Automated image mosaics by non-automated light microscopes: the MicroMos software tool. J Microsc (2013) 0.82
Characterization and role in morphogenesis of a new subviral particle (55S) isolated from poliovirus-infected cells. J Virol (1987) 0.82
Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-gamma. Br J Cancer (2006) 0.82
Mesenchymal stem cells from patients to assay bone graft substitutes. J Cell Physiol (2013) 0.82
Ultrasound and computer tomography in the evaluation of focal liver disease. Acta Radiol Diagn (Stockh) (1981) 0.82
Evidence of loss of N-myc amplification during the establishment of a human neuroblastoma cell line. Int J Cancer (1990) 0.81
[Diminished in vitro colony forming capacity of bone marrow cells in a case of chromosome 8 trisomy (mosaicism): criteria for "high risk" pre-leukemia syndrome]. Boll Ist Sieroter Milan (1981) 0.81
Cytogenetic and molecular study of two human neuroblastoma cell lines. Cancer Genet Cytogenet (1988) 0.81
Stimulation of receptor-coupled phospholipase A2 by interferon-gamma. FEBS Lett (1992) 0.81
The combination of gamma-interferon and tumor necrosis factor causes a rapid and extensive differentiation of human neuroblastoma cells. Cancer Res (1992) 0.80
Lymphoblastoid cells transfected with c-myc: downregulation of EBV-lytic antigens and impaired response of autologous CD4+ T cells in vitro. Int J Cancer (1996) 0.80
N-myc amplification at chromosome band 1p32 in neuroblastoma cells as investigated by in situ hybridization. J Cancer Res Clin Oncol (1988) 0.79
Low-dose interferon-gamma-producing human neuroblastoma cells show reduced proliferation and delayed tumorigenicity. Br J Cancer (2004) 0.79
Presence of telomerase activity in different musculoskeletal tumor histotypes and correlation with aggressiveness. Int J Cancer (2001) 0.79
Mesenchymal stem cells as delivery vehicle of porphyrin loaded nanoparticles: effective photoinduced in vitro killing of osteosarcoma. J Control Release (2013) 0.79
Seasonal variations of date of diagnosis and birth for neuroblastoma patients in Italy. Cancer Epidemiol (2013) 0.79
N-myc oncogene amplification in a patient with IV-S neuroblastoma. Am J Pediatr Hematol Oncol (1987) 0.78
Expression of multiple drug resistance gene, MDR1, and N-myc oncogene in an Italian population of human neuroblastoma patients. Anticancer Res (1990) 0.78
Antiblastic treatment does not affect N-myc gene amplification in neuroblastoma. Anticancer Res (1987) 0.78
Retinoic acid inhibits phosphatidylinositol turnover only in RA-sensitive while not in RA-resistant human neuroblastoma cells. Biochem Biophys Res Commun (1989) 0.78
In vivo study on critical defects using the sheep model. Chir Organi Mov (2006) 0.78
OP-1 application in bone allograft integration: preliminary results in sheep experimental surgery. Injury (2008) 0.78
Interferon-gamma-stimulated and GTP-binding-proteins-mediated phospholipase A2 activation in human neuroblasts. Biochem J (1993) 0.77
Pleomorphic (anaplastic) neuroblastoma in nude mice. Arch Pathol Lab Med (1991) 0.77
Synergistic differentiation-promoting activity of interferon gamma and tumor necrosis factor-alpha: role of receptor regulation on human neuroblasts. J Natl Cancer Inst (1994) 0.77
Signals transduced via insulin-like growth factor I receptor (IGF(R)) mediate resistance to retinoic acid-induced cell growth arrest in a human neuroblastoma cell line. Cell Death Differ (1994) 0.77
Thiophene-based compounds as fluorescent tags to study mesenchymal stem cell uptake and release of taxanes. Bioconjug Chem (2014) 0.77
Modulation of alpha 1 beta 1, alpha 2 beta 1 and alpha 3 beta 1 integrin heterodimers during human neuroblastoma cell differentiation. FEBS Lett (1993) 0.76
Gamma-interferon, retinoic acid, and cytosine arabinoside induce neuroblastoma differentiation by different mechanisms. Cell Mol Neurobiol (1991) 0.76
Cloning and sequencing of isoform-specific regions of human Ca2+-independent protein kinase C (PKC)-encoding genes. Gene (1994) 0.76
Wilms' tumor after treatment. Pediatr Pathol (1992) 0.76
Analysis of the karyotype of expanded human adipose-derived stem cells for bone reconstruction of the maxillo-facial region. Int J Immunopathol Pharmacol (2013) 0.76
Processing of human cord blood by three different procedures for red blood cell depletion and mononuclear cell recovery. Vox Sang (1999) 0.76
N-myc oncogene amplification and catecholamine metabolism in patients with neuroblastoma. Lancet (1987) 0.76
Two-stage phase II study of imatinib mesylate in subjects with refractory or relapsing neuroblastoma. Ann Oncol (2013) 0.75
Cisplatin induces modulation of transferrin receptor during cellular differentiation in vitro. Cancer Chemother Pharmacol (1986) 0.75
Prognostic significance of N-myc amplification in neuroblastoma. Clin Chem (1990) 0.75
[The identification of minimal residual disease in the bone marrow and peripheral blood in neuroblastoma. The prognostic and therapeutic implications]. Pediatr Med Chir (1998) 0.75
Cisplatin-induced erythroid differentiation in K562 cells: modulation of transferrin receptor. Boll Ist Sieroter Milan (1988) 0.75
N-myc oncogene amplification in a pediatric case of glioblastoma multiforme. Childs Nerv Syst (1991) 0.75
Effect of a new peptidyl-hypoxanthine derivative on natural killer cells and antitumor activity. Cancer Detect Prev (1991) 0.75
Resistant and relapsing neuroblastoma: improved response rate with a new multiagent regimen (OC-HDP) including high-dose cisplatinum. Med Pediatr Oncol (1987) 0.75
[Oncogenes and neoplasms in children: solid tumors. I]. Minerva Pediatr (1986) 0.75
Antiherpes activity of 5-(2-bromoethyl)-2'-deoxyuridine. Antiviral Res (1985) 0.75
[Oncogenes and neoplasms in children: hemo-lymphoproliferative diseases. II]. Minerva Pediatr (1986) 0.75
[Serum levels of IgG subclasses in critically ill premature infants treated with intravenous immunoglobulins]. Minerva Pediatr (1991) 0.75
A human acute leukemia-derived T-cell line produces two inhibitor factors which suppress lymphocyte proliferation: characterization and purification of the molecules. Lymphokine Res (1988) 0.75
[Bacterial infectious complications in children with acute lymphoblastic leukemia in the induction phase]. Minerva Pediatr (1983) 0.75
Morphological and biochemical modifications during neuroblastoma cell differentiation. Cytotechnology (1991) 0.75
[Amplification of the N-myc cellular oncogene in neuroblastoma. Relation to other tumor markers]. Boll Ist Sieroter Milan (1986) 0.75
[New line of human neuroblastoma derived from bone marrow]. Pathologica (1987) 0.75
[Activation of cellular N-myc oncogene in neuroblastoma]. Clin Ter (1988) 0.75
Retinol (vitamin A) and retinal-binding protein serum levels in children with cancer at onset. Nutrition (1997) 0.75
High-performance liquid chromatographic determination in human plasma of a new immunomodulatory agent with a peptidyl-hypoxanthine structure (RM 06). J Chromatogr (1990) 0.75
N-myc and MDR1 expression are mutually exclusive in NB tumors at onset. Prog Clin Biol Res (1991) 0.75
Biopharmacokinetic evaluation of peptichemio (PTC) by reversed-phase high-performance liquid chromatography (HPLC): preliminary in vitro studies. Boll Ist Sieroter Milan (1987) 0.75
Bone-marrow T-lymphoid cells: a simple method for enriched specimen. Boll Ist Sieroter Milan (1979) 0.75
In vitro response to mitogens and antigens in elderly and post-cytotoxic patients can be modified by a new hypoxanthine derivative (PCF-39). Boll Ist Sieroter Milan (1987) 0.75
T-gamma lymphocytes in a case of congenital hypoplastic anemia (Diamond-Blackfan syndrome). Haematologica (1981) 0.75
Effect of cytosine arabinoside on the growth and phenotypic expression of GI-ME-N, a new human neuroblastoma cell line. Prog Clin Biol Res (1988) 0.75
In vitro and in vivo immunomodulatory activity of an N-9 arginyl hypoxanthine derivative (PCF-39). Int J Immunopharmacol (1987) 0.75
Different regulation of mid-size neurofilament and N-myc mRNA expression during neuroblastoma cell differentiation induced by retinoic acid. Cell Mol Neurobiol (1990) 0.75
Molecular analysis of HLA class II antigens in bone marrow transplanted thalassemic patients. Haematologica (1992) 0.75
Purification to homogeneity and biochemical characterization of two suppressor factors from human malignant T-cells. Biochem Biophys Res Commun (1988) 0.75
Infantile leukemia with a new chromosomal rearrangement involving 11q. Cancer Genet Cytogenet (1988) 0.75
A pediatric case of cystic lymphangioma of the spleen. J Comput Assist Tomogr (1981) 0.75
EBNA-negative polyclonal B cells derived from a long-term culture of unclassified acute lymphoblastic leukemia: IL-2-like activity of culture's supernatant. Int J Cell Cloning (1986) 0.75
Cystic lymphangioma of the spleen. Report of CT scan findings. Pediatr Radiol (1982) 0.75
Engineering viral promoters for gene transfer to human neuroblasts. Cell Mol Neurobiol (2000) 0.75
[In vitro synthesis of interleukin 2 (IL-2) by T lymphocytes extracted from a lymphoepithelial thymoma. Purification and biochemical characterization]. Boll Ist Sieroter Milan (1985) 0.75
[Cystic lymphangioma of the spleen (author's transl)]. Pediatr Med Chir (1982) 0.75
Sensory neuropeptides (substance P) and 4-11 SP enhance human neutrophils chemiluminescence; the role of L-arginine. Int J Immunopharmacol (1986) 0.75
In vitro pharmacology of metaiodobenzylguanidine uptake, storage and release in human neuroblastoma cells. J Nucl Biol Med (1992) 0.75
Does N-myc amplification correlate with other prognostic factors in advanced neuroblastoma? Preliminary results. Pediatr Hematol Oncol (1986) 0.75
Phosphatidylinositol turnover is not a general regulator of neuroblastoma cell differentiation: comparison between two differentiating agents, retinoic acid and gamma-interferon. FEBS Lett (1989) 0.75
Analysis of CD4 gene expression in human fetal brain and neuroblasts. Cell Mol Neurobiol (1992) 0.75
[Use of OKT3 monoclonal antibodies and anti-TAC for the quantitative evaluation of interleukin-2]. Boll Ist Sieroter Milan (1985) 0.75
Congenital leukemia: persistent spontaneous regression in a patient with an acquired abnormal karyotype. Acta Haematol (1989) 0.75
Neuroblastoma cells circulate in peripheral blood. Pediatr Hematol Oncol (1989) 0.75